Analysed BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
16-04-2026
yahoo.com
Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus
17-04-2026
yahoo.com
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
20-04-2026
yahoo.com
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
21-04-2026
yahoo.com
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
30-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
30-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
01-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
07-05-2026
yahoo.com
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
21-05-2026
yahoo.com
What is the current price of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The current price of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is $4.57.
BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) absolute price change since previous trading day?
The absolute price change of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) since the previous trading day is $0.
BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) percentage price change since previous trading day?
The percentage price change of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The most recent average sentiment score for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The most recent sentiment for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is .
SEC-8K** Filing Available For BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.